Xilio Therapeutics, Inc. (XLO)
8.94
+0.03
(+0.34%)
USD |
NASDAQ |
Sep 09, 16:00
8.94
0.00 (0.00%)
After-Hours: 16:07
Xilio Therapeutics Total Assets (Quarterly) : 154.25M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 154.25M |
| March 31, 2026 | 163.49M |
| December 31, 2025 | 156.69M |
| September 30, 2025 | 133.69M |
| June 30, 2025 | 133.81M |
| March 31, 2025 | 103.72M |
| December 31, 2024 | 71.08M |
| September 30, 2024 | 74.66M |
| June 30, 2024 | 89.87M |
| March 31, 2024 | 82.61M |
| December 31, 2023 | 60.93M |
| September 30, 2023 | 77.84M |
| Date | Value |
|---|---|
| June 30, 2023 | 92.36M |
| March 31, 2023 | 111.50M |
| December 31, 2022 | 139.16M |
| September 30, 2022 | 157.41M |
| June 30, 2022 | 178.13M |
| March 31, 2022 | 196.35M |
| December 31, 2021 | 221.60M |
| September 30, 2021 | 120.72M |
| June 30, 2021 | 140.02M |
| March 31, 2021 | 158.34M |
| December 31, 2020 | 36.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cue Biopharma, Inc. | 30.71M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 81.99M |
| Shareholders Equity (Quarterly) | 72.26M |
| Debt to Equity Ratio | 0.0872 |
| Current Ratio | 4.254 |
| Net Debt Paydown Yield | 0.50% |